Table 1 Prevalence of polypharmacy among adults stratified by population characteristics in overall, year of 1999–2000 and 2017–2018
From: Prevalence and trends of polypharmacy in U.S. adults, 1999–2018
Overall (n = 55,081) | 1999–2000 (n = 4880) | 2017–2018 (n = 5569) | |
|---|---|---|---|
Sex | |||
Men | 4113 (15.5) | 210 (9.3) | 547 (20.2) |
Women | 5035 (17.6) | 298 (11.4) | 581 (20.3) |
Age | |||
20–39 year | 407 (2.2) | 8 (0.5) | 47 (2.8) |
40–64 year | 3524 (15.9) | 188 (10.5) | 404 (17.0) |
≥ 65 year | 5217 (37.1) | 312 (22.4) | 677 (45.1) |
Race | |||
Mexican American | 991 (10.3) | 78 (6.1) | 95 (12.9) |
Other Hispanic | 600 (13.3) | 31 (10.0) | 83 (16.1) |
Non-Hispanic White | 5007 (20.6) | 279 (12.6) | 538 (27.8) |
Non-Hispanic Black | 1975 (17.2) | 103 (11.3) | 279 (21.5) |
Other Race—Including Multi-Racial | 575 (11.2) | 17 (10.4) | 133 (12.3) |
Education level | |||
High School or below | 5132 (18.4) | 339 (11.3) | 559 (22.9) |
College or above | 3993 (14.7) | 163 (8.8) | 566 (18.2) |
Family income-to-poverty ratio (PIR) | |||
≤ 1.0 | 2735 (17.4) | 188 (11.6) | 338 (19.9) |
> 1.0 | 6413 (16.3) | 320 (9.8) | 790 (20.4) |
Disease status | |||
Hypertension | 6822 (35.7) | 347 (23.3) | 862 (40.7) |
High-cholesterol | 5489 (32.5) | 243 (20.8) | 716 (36.8) |
Diabetes | 3673 (55.0) | 184 (38.3) | 523 (59.7) |
Heart disease | 2944 (59.1) | 190 (42.1) | 346 (65.7) |
Respiratory disease | 2854 (30.1) | 161 (21.9) | 371 (34.3) |
Cancer | 1843 (35.7) | 76 (19.7) | 243 (41.3) |